These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28260065)

  • 1. FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
    Ma J; Li J; Yao X; Lin S; Gu Y; Xu J; Deng Z; Ma W; Zhang H
    Oncol Rep; 2017 Apr; 37(4):1935-1942. PubMed ID: 28260065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
    Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F
    Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
    Ma L; Li P; Wang R; Nan Y; Liu X; Jin F
    Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGNL1 is a potential biomarker of cisplatin resistance in non-small cell lung cancer.
    Meng C; Yang Y; Ren P; Ju Q; Jin X; Long Q; Chen X; Wang X; Li F
    Int J Biol Markers; 2022 Sep; 37(3):260-269. PubMed ID: 35791674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
    Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
    J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
    Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
    Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
    Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
    Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation.
    Li P; Ma L; Zhang Y; Ji F; Jin F
    Biomed Pharmacother; 2014 Feb; 68(1):7-12. PubMed ID: 24412084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.
    Karachaliou N; Papadaki C; Lagoudaki E; Trypaki M; Sfakianaki M; Koutsopoulos A; Mavroudis D; Stathopoulos E; Georgoulias V; Souglakos J
    PLoS One; 2013; 8(9):e74611. PubMed ID: 24058603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.
    Zhang Y; Zeng F; Liu X; Li Y; Zhou J; Huang Y; Wang Y; Zhou S; Zhu W; Shu E; Zhou G; Chen G
    Xenobiotica; 2011 Jul; 41(7):593-602. PubMed ID: 21446835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.
    Wang Z; Lu P; Liang Z; Zhang Z; Shi W; Cai X; Chen C
    Growth Factors; 2015; 33(5-6):337-46. PubMed ID: 26430715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.
    Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q
    BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
    PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.